IDXX vs LNTH
Idexx Laboratories Inc. /DE and Lantheus Holdings, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | IDXX | LNTH |
|---|---|---|
| Revenue | $4.3B | $1.5B |
| Net income | $1.1B | $233.6M |
| Gross margin | 61.8% | 61.1% |
| Net margin | 24.6% | 15.2% |
| Return on equity | 66.2% | 21.4% |
| Diluted EPS | $13.08 | $3.41 |
| Dividend / share | — | — |
| Payout ratio | — | −0.2% |
| Free cash flow | $1.1B | $259.9M |
| Equity | $1.6B | $1.1B |
| Net debt / equity | 0.17× | 0.19× |
| Current ratio | 1.23× | 2.70× |
| Revenue CAGR 5y | 9.7% | 35.3% |
| Profit CAGR 5y | 12.7% | — |
IDXX bills 2.8× the revenue of LNTH, and keeps more of each dollar of revenue as profit (24.6% against 15.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | IDXX | LNTH |
|---|---|---|
| FY2025 | $4.3B | $1.5B |
| FY2024 | $3.9B | $1.5B |
| FY2023 | $3.7B | $1.3B |
| FY2022 | $3.4B | $935.1M |
| FY2021 | $3.2B | $425.2M |
| FY2020 | $2.7B | $339.4M |
| FY2019 | $2.4B | $347.3M |
| FY2018 | $2.2B | $343.4M |
| FY2017 | $2.0B | $331.4M |
| FY2016 | $1.8B | $301.9M |
Net income by year
Bottom line
| Fiscal year | IDXX | LNTH |
|---|---|---|
| FY2025 | $1.1B | $233.6M |
| FY2024 | $887.9M | $312.4M |
| FY2023 | $845.0M | $326.7M |
| FY2022 | $679.1M | $28.1M |
| FY2021 | $744.8M | $-71.3M |
| FY2020 | $581.8M | $-13.5M |
| FY2019 | $427.7M | $31.7M |
| FY2018 | $377.0M | $40.5M |
| FY2017 | $263.1M | $123.4M |
| FY2016 | $222.0M | $26.8M |
Advertisement
AdSense · Rectangle 336×280
More in this industry